NO984712L - Enzymatisk prosess for stereoselektiv fremstilling av terapeutiske amider - Google Patents

Enzymatisk prosess for stereoselektiv fremstilling av terapeutiske amider

Info

Publication number
NO984712L
NO984712L NO984712A NO984712A NO984712L NO 984712 L NO984712 L NO 984712L NO 984712 A NO984712 A NO 984712A NO 984712 A NO984712 A NO 984712A NO 984712 L NO984712 L NO 984712L
Authority
NO
Norway
Prior art keywords
enzymatic process
stereoselective preparation
amides
therapeutic amides
therapeutic
Prior art date
Application number
NO984712A
Other languages
English (en)
Norwegian (no)
Other versions
NO984712D0 (no
Inventor
John Crosby
Robert Antony Holt
John David Pittam
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO984712L publication Critical patent/NO984712L/no
Publication of NO984712D0 publication Critical patent/NO984712D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
    • C07C255/14—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and esterified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42—Hydroxy-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO984712A 1996-04-10 1998-10-09 Enzymatisk prosess for stereoselektiv fremstilling av terapeutiske amider NO984712D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9607458.8A GB9607458D0 (en) 1996-04-10 1996-04-10 Enzymatic process for stereoselective preparation of therapeutic amides
PCT/GB1997/000965 WO1997038124A2 (fr) 1996-04-10 1997-04-07 Procede enzymatique pour la preparation stereoselective d'amides therapeutiques

Publications (2)

Publication Number Publication Date
NO984712L true NO984712L (no) 1998-10-09
NO984712D0 NO984712D0 (no) 1998-10-09

Family

ID=10791844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984712A NO984712D0 (no) 1996-04-10 1998-10-09 Enzymatisk prosess for stereoselektiv fremstilling av terapeutiske amider

Country Status (22)

Country Link
US (2) US6110729A (fr)
EP (1) EP0904400B1 (fr)
JP (3) JP3896162B2 (fr)
KR (1) KR20000005286A (fr)
CN (1) CN1215434A (fr)
AR (1) AR008756A1 (fr)
AT (1) ATE291095T1 (fr)
AU (1) AU723526B2 (fr)
BR (1) BR9708532A (fr)
CA (1) CA2251634A1 (fr)
CZ (1) CZ324698A3 (fr)
DE (1) DE69732772T2 (fr)
GB (1) GB9607458D0 (fr)
IL (1) IL126451A0 (fr)
MY (1) MY133666A (fr)
NO (1) NO984712D0 (fr)
NZ (1) NZ331401A (fr)
PL (1) PL329290A1 (fr)
SK (1) SK140198A3 (fr)
TR (1) TR199802019T2 (fr)
WO (1) WO1997038124A2 (fr)
ZA (1) ZA973019B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1175889A (ja) * 1997-07-15 1999-03-23 Mitsubishi Rayon Co Ltd 光学活性α−トリフルオロメチル乳酸及びその対掌体エステルの製造方法及び精製方法
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
DE60036758T2 (de) 1999-08-04 2008-07-24 Sumitomo Chemical Co., Ltd. Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
TR200200550T2 (tr) 1999-09-04 2002-06-21 Astrazeneca Ab Piruvat dehidrojenaz aktivitesini yükselten ikameli n-fenil 2-hidroksi -2- metil -3,3,3- triflüoropropanamid türevleri.
WO2001017942A1 (fr) 1999-09-04 2001-03-15 Astrazeneca Ab Amides inhibiteurs pour la pyruvate deshydrogenase
ES2273725T3 (es) 1999-09-04 2007-05-16 Astrazeneca Ab Derivados de hidroxiacetamidobencenosulfonamida.
EP1422226A1 (fr) * 2002-11-25 2004-05-26 Tosoh Corporation Composés fluorés optiquement actifs et leur préparation
JP4529419B2 (ja) * 2002-11-25 2010-08-25 東ソー株式会社 光学活性含フッ素化合物類、及びこれらの製造方法
JP2007217440A (ja) * 2007-06-06 2007-08-30 Mitsubishi Rayon Co Ltd 光学活性α−トリフルオロメチル乳酸の精製方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2541466A (en) * 1949-05-21 1951-02-13 Eastman Kodak Co Alpha-fluoromethyl acrylonitriles and copolymers thereof
JPS59205989A (ja) * 1983-05-09 1984-11-21 Sumitomo Chem Co Ltd 光学活性なアルコ−ル化合物の生化学的製法
DE3528265A1 (de) * 1985-08-07 1987-02-12 Bayer Ag Phosphonsaeureester
US4929760A (en) * 1987-11-24 1990-05-29 Showa Shell Sekiyu Kabushiki Kaisha Fluorine-containing carbonyl compounds and method for preparing the same
JPH03254694A (ja) * 1990-03-01 1991-11-13 Kurita Water Ind Ltd 光学活性な含フッ素アルコールの製造方法
GB9005467D0 (en) * 1990-03-12 1990-05-09 Ici Plc Process for the preparation of optically active intermediates for insecticidal compounds
JP3010497B2 (ja) * 1990-05-31 2000-02-21 チッソ株式会社 光学活性α―ヒドロキシエステル類の製造方法
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
JP3133480B2 (ja) * 1992-04-15 2001-02-05 昭和シェル石油株式会社 光学活性ハロゲン含有アルコールの製造方法
US5334534A (en) * 1992-04-15 1994-08-02 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Enzymatic preparation of optically active propanolol and β-adrenergic blockers using esterase
GB9304256D0 (en) * 1993-03-03 1993-04-21 Chiros Ltd Arylalkanoic acid resolution
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
CN1085251C (zh) * 1993-07-02 2002-05-22 尤尼剑马化学股份有限公司 羧酸与叔醇的酯化方法
BE1007297A3 (nl) * 1993-07-19 1995-05-09 Dsm Nv Werkwijze voor de bereiding van optisch aktieve alcoholen en esters, en alcoholen en esters toegepast en bereid in dergelijke werkwijzen.
GB9322472D0 (en) * 1993-11-01 1993-12-22 Chiros Ltd Chiral compounds and their preparation

Also Published As

Publication number Publication date
KR20000005286A (ko) 2000-01-25
AU723526B2 (en) 2000-08-31
EP0904400B1 (fr) 2005-03-16
DE69732772T2 (de) 2005-10-27
EP0904400A2 (fr) 1999-03-31
JP2006345873A (ja) 2006-12-28
WO1997038124A3 (fr) 1997-12-18
CA2251634A1 (fr) 1997-10-16
CZ324698A3 (cs) 1999-01-13
NZ331401A (en) 2000-06-23
AR008756A1 (es) 2000-02-23
IL126451A0 (en) 1999-08-17
WO1997038124A2 (fr) 1997-10-16
BR9708532A (pt) 1999-08-03
ZA973019B (en) 1997-10-10
DE69732772D1 (de) 2005-04-21
JP2005287514A (ja) 2005-10-20
CN1215434A (zh) 1999-04-28
GB9607458D0 (en) 1996-06-12
JP2000509254A (ja) 2000-07-25
SK140198A3 (en) 1999-03-12
TR199802019T2 (xx) 1999-04-21
PL329290A1 (en) 1999-03-15
AU2302897A (en) 1997-10-29
US6110729A (en) 2000-08-29
US6261830B1 (en) 2001-07-17
JP3896162B2 (ja) 2007-03-22
MY133666A (en) 2007-11-30
NO984712D0 (no) 1998-10-09
ATE291095T1 (de) 2005-04-15

Similar Documents

Publication Publication Date Title
NO990756L (no) FremgangsmÕte for fremstilling av mellomprodukter for florfenikol
NO986051D0 (no) Antikonvulsive derivater for behandling av manisk-depressive mangler
HUP9900422A3 (en) Novel protein and methods for the production of the same
AU3075795A (en) Anti-helicobacter acyl derivatives of azolones
AU4589297A (en) Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
NO962750D0 (no) Fremgangsmåte for fremstilling av buten-1
AU7412196A (en) 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of beta-amyloid protein production
NO970212L (no) Fremgangsmåte for fremstilling av enantiomerene av O-demetyltramadol
AU2713197A (en) Process for stereoselective preparation of 4-acetoxyazetidinones
NO991382D0 (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO984712D0 (no) Enzymatisk prosess for stereoselektiv fremstilling av terapeutiske amider
AU4259296A (en) Process for preparation of supports
HU9700077D0 (en) Anti-helicobacter heterocyclic derivatives of azolones
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
NO20001777D0 (no) Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer
EP0736323A3 (fr) Procédé de préparation d'un gel micro-mesoporeux
AU5156098A (en) Process for the combined synthesis of betaine and choline chloride
NO179244C (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
NO984206D0 (no) Fremgangsmåte for fremstilling av N-beskyttende D-prolinderivater
HUP9902743A3 (en) Enzymatic process for stereoselective preparation of therapeutic amides
NO991055L (no) FremgangsmÕte for fremstilling av dinitratestere
GB9705850D0 (en) Enzymatic process for stereoslective preparation of therapeutic amides
EG20611A (en) Process for the production of indole derivatives
HUP0002449A3 (en) Process for producing 3-fluoro oxindole derivatives and intermediates of the preparation
NO990185L (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application